JP2020534259A5 - - Google Patents

Download PDF

Info

Publication number
JP2020534259A5
JP2020534259A5 JP2020513700A JP2020513700A JP2020534259A5 JP 2020534259 A5 JP2020534259 A5 JP 2020534259A5 JP 2020513700 A JP2020513700 A JP 2020513700A JP 2020513700 A JP2020513700 A JP 2020513700A JP 2020534259 A5 JP2020534259 A5 JP 2020534259A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
heterocyclyl
cycloalkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020513700A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020534259A (ja
JP7128264B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2018/104559 external-priority patent/WO2019047915A1/en
Publication of JP2020534259A publication Critical patent/JP2020534259A/ja
Publication of JP2020534259A5 publication Critical patent/JP2020534259A5/ja
Application granted granted Critical
Publication of JP7128264B2 publication Critical patent/JP7128264B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020513700A 2017-09-08 2018-09-07 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体 Active JP7128264B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CNPCT/CN2017/101058 2017-09-08
CN2017101058 2017-09-08
CNPCT/CN2017/119373 2017-12-28
CN2017119373 2017-12-28
CNPCT/CN2018/086555 2018-05-11
CN2018086555 2018-05-11
PCT/CN2018/104559 WO2019047915A1 (en) 2017-09-08 2018-09-07 IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3KDELTA INHIBITORS

Publications (3)

Publication Number Publication Date
JP2020534259A JP2020534259A (ja) 2020-11-26
JP2020534259A5 true JP2020534259A5 (cg-RX-API-DMAC10.html) 2021-09-24
JP7128264B2 JP7128264B2 (ja) 2022-08-30

Family

ID=65633578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020513700A Active JP7128264B2 (ja) 2017-09-08 2018-09-07 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体

Country Status (21)

Country Link
US (3) US11220506B2 (cg-RX-API-DMAC10.html)
EP (2) EP4219502A1 (cg-RX-API-DMAC10.html)
JP (1) JP7128264B2 (cg-RX-API-DMAC10.html)
KR (1) KR20200052297A (cg-RX-API-DMAC10.html)
CN (2) CN111704615B (cg-RX-API-DMAC10.html)
AU (2) AU2018328569B2 (cg-RX-API-DMAC10.html)
BR (1) BR112020004500A2 (cg-RX-API-DMAC10.html)
CA (1) CA3072842A1 (cg-RX-API-DMAC10.html)
DK (1) DK3679042T3 (cg-RX-API-DMAC10.html)
ES (1) ES2944658T3 (cg-RX-API-DMAC10.html)
FI (1) FI3679042T3 (cg-RX-API-DMAC10.html)
HU (1) HUE061898T2 (cg-RX-API-DMAC10.html)
IL (1) IL272988B (cg-RX-API-DMAC10.html)
MX (1) MX2020002630A (cg-RX-API-DMAC10.html)
NZ (1) NZ761680A (cg-RX-API-DMAC10.html)
PL (1) PL3679042T3 (cg-RX-API-DMAC10.html)
PT (1) PT3679042T (cg-RX-API-DMAC10.html)
SG (1) SG11202001286SA (cg-RX-API-DMAC10.html)
TW (2) TWI817956B (cg-RX-API-DMAC10.html)
WO (1) WO2019047915A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202000875B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX394882B (es) 2016-12-07 2025-03-24 Beigene Ltd Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta)
NZ761680A (en) 2017-09-08 2023-03-31 Beigene Ltd Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors
US20230011916A1 (en) * 2019-11-21 2023-01-12 Beigene, Ltd. Methods of cancer treatment using anti-ox40 antibodies in combination with pi3 kinase delta inhibitors
JP2024521763A (ja) * 2021-05-27 2024-06-04 ベイジーン スウィッツァーランド ゲーエムベーハー Pi3kデルタ阻害剤の塩、その結晶形態、調製方法、及び使用
TW202327611A (zh) * 2021-09-14 2023-07-16 英屬開曼群島商百濟神州有限公司 使用btk抑制劑和p13激酶抑制劑的組合治療癌症之方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005089352A (ja) * 2003-09-16 2005-04-07 Kissei Pharmaceut Co Ltd 新規なイミダゾ[1,5−a]ピラジン誘導体、それを含有する医薬組成物およびそれらの用途
ES2372694T3 (es) * 2003-10-15 2012-01-25 OSI Pharmaceuticals, LLC Inhibidores de tirosina cinasa de imidazo[1,5-a]pirazina.
EP1981890A2 (en) * 2006-01-25 2008-10-22 OSI Pharmaceuticals, Inc. UNSATURATED mTOR INHIBITORS
EP2419425A4 (en) * 2009-04-15 2012-08-29 Astrazeneca Ab IMIDAZOLE SUBSTITUTED PYRIMIDINES USEFUL IN THE TREATMENT OF GLYCOGEN SYNTHASE KINASE 3 RELATED DISORDERS, SUCH AS ALZHEIMER'S DISEASE
NZ596185A (en) 2009-04-16 2013-01-25 Ct Nac Investigaciones Oncologicas Cnio Imidazopyrazines for use as kinase inhibitors
US8653089B2 (en) * 2011-02-09 2014-02-18 F. Hoffmann-La Roche Ag Heterocyclic compounds and methods of use
CA2860723A1 (en) * 2012-01-10 2013-07-18 Bayer Intellectual Property Gmbh Substituted imidazopyrazines as akt kinase inhibitors
RU2702908C2 (ru) * 2012-11-01 2019-10-14 Инфинити Фармасьютикалз, Инк. Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы
TWI736135B (zh) * 2013-03-01 2021-08-11 美商英塞特控股公司 吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
KR20160013204A (ko) 2013-05-30 2016-02-03 인피니티 파마슈티칼스, 인코포레이티드 Pi3 키나아제 동형단백질 조절제를 사용하는 암의 치료
WO2015058084A1 (en) * 2013-10-18 2015-04-23 Medivation Technologies, Inc. Heterocyclic compounds and methods of use
SMT202100674T1 (it) * 2014-08-11 2022-01-10 Acerta Pharma Bv Combinazioni terapeutiche di un inibitore di btk e un inibitore di bcl-2
AR102220A1 (es) * 2015-10-08 2017-02-15 Incyte Corp Imidazopiridinas e imidazopirazinas como inhibidores de lsd1
CN109311875A (zh) * 2016-06-16 2019-02-05 詹森药业有限公司 作为PI3Kβ抑制剂的二环吡啶、二环吡嗪、和二环嘧啶衍生物
MX394882B (es) 2016-12-07 2025-03-24 Beigene Ltd Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta)
NZ761680A (en) 2017-09-08 2023-03-31 Beigene Ltd Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors

Similar Documents

Publication Publication Date Title
JP2020500909A5 (cg-RX-API-DMAC10.html)
JP7738619B2 (ja) Erbb/btk阻害剤
CN111686110B (zh) 用于调节egfr突变体激酶活性的化合物和组合物
JP6545106B2 (ja) PI3Kδ関連障害治療のためのピラゾロピリミジン誘導体の使用
WO2016160617A3 (en) Inhibitors of cyclin-dependent kinases
JP2018507877A5 (cg-RX-API-DMAC10.html)
EP4277901A1 (en) Isoindolinone compounds
RU2014134388A (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
WO2016105528A3 (en) Inhibitors of cyclin-dependent kinase 7 (cdk7)
JP2016523973A5 (cg-RX-API-DMAC10.html)
JP2022507267A5 (cg-RX-API-DMAC10.html)
CN111467346B (zh) 具有四氢吡喃基甲基的吡啶酮衍生物
WO2017044858A3 (en) Inhibitors of cyclin-dependent kinases
RU2014130125A (ru) Новые пиррольные соединения, способ их получения и фармацевтические композиции, содержащие их
JP2019516766A5 (cg-RX-API-DMAC10.html)
JP2018532737A5 (cg-RX-API-DMAC10.html)
WO2020186027A1 (en) Inhibitors of cgas for treating autoinflammatory diseases and cancer metastasis
WO2022219412A1 (en) Isoindolinone amide compounds useful to treat diseases associated with gspt1
JP7197558B2 (ja) A2a阻害剤及び癌の治療に使用するための化合物としての2-オキソ-チアゾール誘導体
JP2008528467A5 (cg-RX-API-DMAC10.html)
DK2722332T3 (en) Quinolylpyrrolopyrimidylforbindelse with concentrated ring or salt thereof.
RU2016106002A (ru) Новые индольные и пиррольные соединения, способ их получения и фармацевтические композиции, содержащие их
JP2013523802A5 (cg-RX-API-DMAC10.html)
IL272988B (en) Imidazo-[1,5-a]pyrazine derivatives as pi3k-delta inhibitors
JP2023520330A5 (cg-RX-API-DMAC10.html)